BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,749 | -1.5% | 79,000 | 0.0% | 0.00% | – |
| Q2 2023 | $77,902 | -3.9% | 79,000 | 0.0% | 0.00% | – |
| Q1 2023 | $81,050 | -86.8% | 79,000 | -86.3% | 0.00% | -100.0% |
| Q4 2022 | $612,712 | -1.2% | 575,000 | -8.0% | 0.00% | 0.0% |
| Q3 2022 | $620,000 | -9.4% | 625,000 | -9.3% | 0.00% | 0.0% |
| Q2 2022 | $684,000 | -31.7% | 689,000 | -30.9% | 0.00% | -50.0% |
| Q1 2022 | $1,002,000 | -21.7% | 997,000 | -17.9% | 0.00% | 0.0% |
| Q4 2021 | $1,280,000 | +48.3% | 1,214,000 | +45.2% | 0.00% | +100.0% |
| Q3 2021 | $863,000 | +9.4% | 836,000 | +10.6% | 0.00% | 0.0% |
| Q2 2021 | $789,000 | -64.3% | 756,000 | -65.6% | 0.00% | -75.0% |
| Q4 2017 | $2,207,000 | +81.3% | 2,200,000 | +83.3% | 0.00% | +100.0% |
| Q3 2017 | $1,217,000 | – | 1,200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
| SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
| SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
| PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
| RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
| Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
| Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
| MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
| Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |